1. 1. Mehrgan H, Rahbar M. Prevalence of extended-spectrum β-lactamase-producing Escherichia coli in a tertiary care hospital in Tehran, Iran. Int J Antimicrob Agents. 2008; 31 (2): 147-51.
2. Tayh G, Sallem RB, Yahia HB, Gharsa H, Klibi N, Boudabous A, Slama KB. First report of extended-spectrum β-lactamases among clinical isolates of Escherichia coli in Gaza Strip, Palestine. J Glob Antimicrob Resist. 2016; 6: 17-21.
3. Bradford PA. Extended-spectrum β-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clin Microbiol Rev. 2001; 14 (4): 933-51.
4. Turner PJ. Extended-spectrum β-lactamases. Clin Infect Dis. 2005; 41 (Supplement 4): S273-S5.
5. Tayh G, Al Laham N, Elmanama A, SLAMA KB. Occurrence and antimicrobial susceptibility pattern of ESBL among Gram-negative bacteria isolated from burn unit of Al Shifa hospital in Gaza, Palestine. Int Arab J Antimicrob Agents. 2016; 5 (3).
6. Astal Z, Sharif FA, Abdallah SA, Fahd MI. Extended spectrum beta-lactamases in Eschericia coli isolated from community-acquired urinary tract infections in the Gaza Strip, Palestine. Ann Saudi Med. 2004; 24 (1): 55-7.
7. Adwan G, Abu Jaber A. Frequency and molecular characterization of β-lactamases producing Escherichia coli isolated from North of Palestine. Br Microbiol Res J. 2016; 11 (5): 1-13.
8. Al-Zarouni M, Senok A, Rashid F, Al-Jesmi SM, Panigrahi D. Prevalence and antimicrobial susceptibility pattern of extended-spectrum beta-lactamase-producing Enterobacteriaceae in the United Arab Emirates. Med Princ Pract. 2008; 17 (1): 32-6.
9. Ibrahim ALS, Youssef N. Prevalence of CTX-M, TEM and SHV Beta-lactamases in Clinical Isolates of Escherichia Coli and Klebsiella Pneumoniae Isolated From Aleppo University Hospitals, Aleppo, Syria. Arch Clin Infect Dis. 2015; 10 (2): e22540.
10. Shehabia AA, Mahafzah A, Baadran I, Qadar FA, Dajani N. High incidence of Klebsiella pneumoniae clinical isolates to extended-spectrum B-lactam drugs in intensive care units. Diagn Microbiol Infect Dis. 2000; 36 (1): 53-6.
11. Cheaito K, Matar GM. The Mediterranean Region: A Reservoir for CTX-M-ESBL-Producing Enterobacteriacae. J JBS. 2014; 7: 1-6.
12. Batchoun RG, Swedan SF, Shurman AM. Extended Spectrum ß-Lactamases among Gram-negative Bacterial Isolates from Clinical Specimens in Three Major Hospitals in Northern Jordan. Int J Microbiol. 2009; 2009: 513874.
13. Hassan WM, Hashim A, Domany RAA. Plasmid mediated quinolone resistance determinants qnr, aac(6')-Ib-cr, and qep in ESBL-producing Escherichia coli clinical isolates from Egypt. Indian J Med Microbiol. 2012; 30 (4): 442.
14. Al-Assil B, Mahfoud M, Hamzeh AR. Resistance trends and risk factors of extended spectrum ß-lactamases in Escherichia coli infections in Aleppo, Syria. Am J Infect Control. 2013; 41 (7): 597-600.
15. Wayne P. CLSI performance standard of antimicrobial susceptibility testing: twenty-fourth international supplement. CLSI Document M100-S24, Clinical and Laboratory Standard Institute. 2014; 34 (1): 50-106.
16. Naik J, Desai P. Antibiotic resistance pattern in urinary isolates of Escherichia coli with special reference to extended spectrum β-Lactamases production. Int J Univers Pharm Life Sci. 2012; 3 (3): 0976-7126.
17. Jouini A, Vinué L, Slama KB, Saenz Y, Klibi N, Hammami S, Boudabous A, Torres C. Characterization of CTX-M and SHV extended-spectrum β-lactamases and associated resistance genes in Escherichia coli strains of food samples in Tunisia. J Antimicrob Chemother. 2007; 60 (5): 1137-41.
18. Hadadi A, Rasoulinejad M, Maleki Z, Yonesian M, Shirani A, Kourorian Z. Antimicrobial resistance pattern of Gram-negative bacilli of nosocomial origin at 2 university hospitals in Iran. Diagn Microbiol Infect Dis. 2008; 60 (3): 301-5.
19. Peterson DL, Ko WC, Gottberg AV, Mohapatra S, Casellas JM, Goossens H. International prospective study of Klebsiella pneumoniae bacteremia implication of extended-spectrum beta-lactamase production in nosocomial infections. Ann Intern Med. 2004; 140: 26-32.
20. El Astal ZY, Ramadan H. Occurrence of Extended-Spectrum Beta-Lactamases in isolates of Klepsiella pneumoniae and Escherichia coli. Inter J Integr Biol. 2008; 2 (2): 123-8.
21. Al-Masri M, Abu-Hasan N, Jouhari MM. Extended Spectrum β-lactamases in Clinical Isolates of Escherichia coli and Enterobacter cloacae Collected from Nablus District-Palestine. Br Microbiol Res J. 2016; 16 (3): 1-7.
22. Jamal W, Rotimi VO, Khodakhast F, Saleem R, Pazhoor A, Al Hashim G. Prevalence of extended-spectrum beta-lactamases in Enterobacteriaceae, Pseudomonas and Stenotrophomonas as determined by the VITEK 2 and E test systems in a Kuwait teaching hospital. Med Princ Pract. 2005; 14 (5): 325-31.
23. Seni J, Sweya E, Mabewa A, Mshana SE, Gilyoma JM. Comparison of antimicrobial resistance patterns of ESBL and non ESBL bacterial isolates among patients with secondary peritonitis at Bugando Medical Centre, Mwanza–Tanzania. BMC emergency medicine. 2016; 16 (1): 41.
24. Kucukates E. Antimicrobial resistance among Gram-negative bacteria isolated from intensive care units in a Cardiology Institute in Istanbul, Turkey. Jpn J Infect Dis. 2005; 58 (4): 228.
25. Thomson KS, Moland ES. Cefepime, piperacillin-tazobactam, and the inoculum effect in tests with extended-spectrum β-lactamase-producing Enterobacteriaceae. Antimicrob Agents Chemother. 2001; 45 (12): 3548-54.
26. Alipourfard I, Nili NY. Antibiogram of Extended Spectrum Beta-lactamase (ESBL) producing Escherichia coli and Klebsiella pneumoniae isolated from Hospital Samples. Bangladesh j med microbiol. 2010; 4 (1): 32-6.
27. Saurina G, Quale JM, Manikal VM, Oydna E, Landman D. Antimicrobial resistance in Enterobacteriaceae in Brooklyn, NY: epidemiology and relation to antibiotic usage patterns. J Antimicrob Chemother. 2000; 45 (6): 895-8.
28. Serefhanoglu K, Turan H, Timurkaynak FE, Arslan H. Bloodstream infections caused by ESBL-producing E. coli and K. pneumoniae: risk factors for multidrug-resistance. Braz J Infect Dis. 2009; 13 (6): 403-7.
29. Somily AM, Habib HA, Absar MM, Arshad MZ, Manneh K, Al Subaie SS, Al Hedaithy MA, Sayyed SB, Shakoor Z, Murray TS. ESBL-producing Escherichia coli and Klebsiella pneumoniae at a tertiary care hospital in Saudi Arabia. J Infect Dev Ctries. 2014; 8 (09): 1129-36.
30. Poovendran P, Vidhya N, Murugan S. Antimicrobial susceptibility pattern of ESBL and non-ESBL producing uropathogenic Escherichia coli (UPEC) and their correlation with biofilm formation. Intl J Microbiol Res. 2011; 4 (1): 56-63.
2. Prevalence of extended-spectrum β-lactamase-producing Escherichia coli in a tertiary care hospital in Tehran, Iran
3. First report of extended-spectrum β-lactamases among clinical isolates of Escherichia coli in Gaza Strip, Palestine
4. Extended-Spectrum β-Lactamases in the 21st Century: Characterization, Epidemiology, and Detection of This Important Resistance Threat
5. Extended‐Spectrum β‐Lactamases